AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tas, M. W.
Right arrow Articles by Valk, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tas, M. W.
Right arrow Articles by Valk, J.

American Journal of Neuroradiology, Vol 16, Issue 2 259-264, Copyright © 1995 by American Society of Neuroradiology


ARTICLES

The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis

MW Tas, F Barkhol, MA van Walderveen, CH Polman, OR Hommes and J Valk
Department of Diagnostic Radiology, Free University Hospital, Amsterdam, The Netherlands.

PURPOSE: To determine whether gadolinium can improve the sensitivity and specificity of MR imaging for the initial diagnosis of multiple sclerosis. METHODS: Patients (n = 57) with neurologic symptoms suggesting multiple sclerosis were studied prospectively. MR imaging consisted of T2-weighted and gadolinium-enhanced T1-weighted spin-echo images. Lumbar puncture was performed for cerebrospinal fluid analysis in 34 patients. RESULTS: After imaging, 17 patients (35%) had clinically definite multiple sclerosis. Cerebrospinal fluid examination had a sensitivity of 69% and specificity of 38%. Using liberal criteria, the sensitivity of T2-weighted MR imaging was 94% and the specificity 55%; using more strict criteria, the specificity increased to 65% with a sensitivity of 88%. Gadopentetate dimeglumine enhancement increased the specificity further to 80% with a loss of sensitivity (59%). CONCLUSION: Gadolinium enhancement increases the specificity of MR imaging in the early diagnosis of multiple sclerosis.


This article has been cited by other articles:


Home page
Arch NeurolHome page
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al.
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol, May 1, 2009; 66(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Scozzafava, H. Block, N. Asdaghi, and Z. A. Siddiqi
Teaching NeuroImage: Cryptococcal brain pseudocysts in an immunocompetent patient
Neurology, August 28, 2007; 69(9): E6 - E7.
[Full Text] [PDF]


Home page
RadiologyHome page
K. R. Maravilla, J. A. Maldjian, I. M. Schmalfuss, M. J. Kuhn, B. C. Bowen, F. J. Wippold II, V. M. Runge, M. V. Knopp, S. Kremer, L. J. Wolansky, et al.
Contrast Enhancement of Central Nervous System Lesions: Multicenter Intraindividual Crossover Comparative Study of Two MR Contrast Agents
Radiology, August 1, 2006; 240(2): 389 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J.H. Simon, D. Li, A. Traboulsee, P.K. Coyle, D.L. Arnold, F. Barkhof, J.A. Frank, R. Grossman, D.W. Paty, E.W. Radue, et al.
Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus Guidelines.
AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 455 - 461.
[Full Text] [PDF]


Home page
Arch NeurolHome page
A. Minneboo, F. Barkhof, C. H. Polman, B. M. J. Uitdehaag, D. L. Knol, and J. A. Castelijns
Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis
Arch Neurol, February 1, 2004; 61(2): 217 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
F. Sardanelli, A. Iozzelli, C. Losacco, A. Murialdo, and M. Filippi
Three Subsequent Single Doses of Gadolinium Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR Am. J. Neuroradiol., April 1, 2003; 24(4): 658 - 662.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
CHAMPS Study Group
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
Neurology, October 8, 2002; 59(7): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
O. Gonen, D. M. Moriarty, B. S. Y. Li, J. S. Babb, J. He, J. Listerud, D. Jacobs, C. E. Markowitz, and R. I. Grossman
Relapsing-remitting Multiple Sclerosis and Whole-Brain N-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations
Radiology, October 1, 2002; 225(1): 261 - 268.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
CHAMPS Study Group
Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial
Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338.
[Abstract] [PDF]


Home page
NeurologyHome page
D. L. Arnold and P.M. Matthews
MRI in the diagnosis and management of multiple sclerosis
Neurology, April 23, 2002; 58(90084): S23 - 31.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
J. S. Kaiser, R. I. Grossman, M. Polansky, J. K. Udupa, Y. Miki, and S. L. Galetta
Magnetization Transfer Histogram Analysis of Monosymptomatic Episodes of Neurologic Dysfunction: Preliminary Findings
AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1043 - 1047.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706.
[Abstract] [Full Text]


Home page
NeurologyHome page
J. H. Simon, R. P. Kinkel, L. Jacobs, L. Bub, and N. Simonian
A Wallerian degeneration pattern in patients at risk for MS
Neurology, March 14, 2000; 54(5): 1155 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R P Kinkel, J H Simon, and B Baron
Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis `prevention' trials
Multiple Sclerosis, October 1, 1999; 5(5): 307 - 312.
[Abstract] [PDF]


Home page
NeurologyHome page
P. A. Brex, J. I. O'Riordan, K. A. Miszkiel, I. F. Moseley, A. J. Thompson, G. T. Plant, and D. H. Miller
Multisequence MRI in clinically isolated syndromes and the early development of MS
Neurology, October 1, 1999; 53(6): 1184 - 1184.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al.
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
Neurology, August 1, 1999; 53(3): 448 - 448.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. C Fulton, R. I Grossman, L. J Mannon, J. Udupa, and D. L Kolson
Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals
Multiple Sclerosis, April 1, 1999; 5(2): 74 - 77.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. Breslau, J. G. Jarvik, D. R. Haynor, W. T. Longstreth Jr, D. L. Kent, and K. R. Maravilla
MR Contrast Media in Neuroimaging: A Critical Review of the Literature
AJNR Am. J. Neuroradiol., April 1, 1999; 20(4): 670 - 675.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357.
[Abstract] [Full Text] [PDF]